You have 9 free searches left this month | for more free features.

City

Bethesda (1)

Liege (1)

Condition

Chronic Granulomatous Disease (1)

Hematologic Malignancies (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID) (1)

University of Liege (1)

Collaborator

Intervention

baxter isolex 300i (1)

cd8-depleted pbsc after nonmyeloablative conditioning (1)

nexell isolex with t-cell depletion (1)

unmanipulated pbsc after nonmyeloablative conditioning (1)

Study Documents

Intervention Type

device (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

Minitransplant

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hematologic Malignancies Trial in Liege (Unmanipulated PBSC after nonmyeloablative conditioning, CD8-depleted PBSC after

Completed

Hematologic Malignancies

Unmanipulated PBSC after nonmyeloablative conditioning
CD8-depleted PBSC after nonmyeloablative conditioning

Liege, Belgium

CHU Sart Tilman

Sep 1, 2011

Chronic Granulomatous Disease Trial run by the NIAID (Nexell Isolex with T-cell Depletion, Baxter isolex 300i)

Completed

Chronic Granulomatous Disease

Nexell Isolex with T-cell Depletion
Baxter isolex 300i

Bethesda, Maryland

National Institute of Allergy and Infectious Diseases (NIAID)

Mar 3, 2008